People with comorbid alcohol use disorder and obesity may represent a distinct clinical subgroup, with glucose dysregulation ...

Cedars-Sinai Health Sciences University investigators have identified molecular mechanisms that drive inflammation in alcohol ...

A recent perspective published in eGastroenterology, Professor Wen-Xing Ding and colleagues from The University of Kansas ...

For decades, giant mitochondria-known as megamitochondria-have been recognized in liver biopsies from patients with alcohol-associated liver disease (ALD).

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...

The findings add to a growing body of research suggesting these medications may be useful as cancer prevention tools, ...

Researchers at the University of Colorado Anschutz Medical Campus observed unusual changes in brain connectivity while ...

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

Can semaglutide reduce alcohol consumption? New research explores its role in alcohol use disorder and obesity.

It’s called the aperitif effect – why we tend to crave something salty when we have a drink or two.

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the ...

This four-paper Series and accompanying comments examine the growing but under-recognised burden of chronic liver disease in Europe, with a focus on steatotic liver disease, including metabolic ...